NHS England has approved routine funding for a stream of new specialised treatments, including stroke-reducing heart implants and a life changing surgical procedure for children with cerebral palsy.
9th July 2018
Vertex and NHS England remain locked in a battle over the provision of cystic fibrosis drug Orkambi, seemingly no closer to a settlement that would allow patients access to the drug on the NHS.
9th July 2018
Actelion’s Uptravi will not be funded on the NHS for patients with Pulmonary Arterial Hypertension (PAH), after the drug failed to make it into NHS England’s latest round of specialised commissioning approvals.
9th July 2018
European regulators have agreed to review Clovis’ application to expand the use of its PARP inhibitor Rubraca in the region.
9th July 2018
The PharmaTimes Marketer of the Year competition is celebrating it's 25th anniversary and with a number companies including Sanofi, PharmaLex, Thornton & Ross, Roche, Bayer, Consilient Health, Cycle Pharmaceuticals and others already entered, it could just be the most exciting one to date.
6th July 2018
The European Medicines Agency is reviewing medicines containing valsartan supplied by a facility in China after a potentially cancer-causing impurity was detected.
6th July 2018
Shares in UK group Sinclair Pharma shot up nearly 40 percent after it confirmed interest from Chinese firms with regard to a possible take-over.
6th July 2018
At last some good news for Alzheimer’s research, as Eisai and Biogen’s experimental anti beta-amyloid therapy BAN2401 hit targets in a Phase II trial in patients with the disease.
6th July 2018
Erik Nordkamp, managing director of Pfizer UK, has been named as the new president of the Association of the British Pharmaceutical Industry (ABPI).
6th July 2018
Celgene has presented Phase III data showing a significant progression-free survival (PFS) benefit in patients with multiple myeloma taking a triple combination therapy of Imnovid, Velcade and low-dose dexamethasone.
5th July 2018
The vast majority of the public would be willing to accept tax increases to secure significant improvements in the NHS, finds a new poll by Ipos Mori commissioned by the NHS Confederation.
5th July 2018
The National Institute for Health and Care Excellence has now issued final guidance rejecting NHS funding for use of Bristol-Myers Squibb’s Opdivo as a treatment for locally advanced unresectable or metastatic urothelial carcinoma (mUC).
4th July 2018
Genomics England says the 100,000 Genomes Project is “well on track” to reach its target of sequencing 100,000 genomes by the end of this year.
4th July 2018
MSD’s Prevymis has not won the support of NHS cost regulators for preventing cytomegalovirus (CMV) reactivation and disease in prone adults who have received an allogeneic haematopoietic stem cell transplant (HSCT).
4th July 2018
Merz Neuroscience’s Xeomin has become the first agent to be approved by the US Food and Drug Administration to treat excessive drooling.
4th July 2018
